Pangaea Oncology, S.A. (BME:PANG)
Spain · Delayed Price · Currency is EUR 1.700
0.00 (0.00%)
At close: Dec 4, 2025
Pangaea Oncology Market Cap
Pangaea Oncology has a market cap or net worth of €58.4 million as of December 5, 2025. Its market cap has decreased by -5.03% in one year.
Market Cap
58.40M
Enterprise Value
61.09M
Revenue
14.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.70
Market Cap Chart
Since December 29, 2016, Pangaea Oncology's market cap has increased from 30.03M to 58.40M, an increase of 94.51%. That is a compound annual growth rate of 7.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 58.40M | -3.95% |
| Dec 31, 2024 | 60.81M | 12.24% |
| Dec 29, 2023 | 54.18M | 8.35% |
| Dec 30, 2022 | 50.00M | 41.34% |
| Dec 30, 2021 | 35.38M | 30.94% |
| Dec 31, 2020 | 27.02M | -5.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.36B |
| Laboratorios Farmaceuticos Rovi | 3.03B |
| Almirall | 2.73B |
| Faes Farma | 1.48B |
| Pharma Mar | 1.25B |
| Clínica Baviera | 754.17M |
| Oryzon Genomics | 250.75M |
| Prim, S.A. | 233.12M |